Glargine Insulin

18 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3330.0%

Death Rate

Active Ingredients

Glargine Insulin

Administration Routes

SubcutaneousUnknownOral

Species Affected

Cat 15

Dog 2

Human 1

Most Affected Breeds

Domestic Shorthair 7

Domestic Longhair 2

Himalayan 2

Ragdoll 1

Retriever - Golden 1

Unknown 1

Cat (other) 1

Domestic Mediumhair 1

Shepherd Dog - German 1

Siamese 1

Most Reported Reactions

Death by euthanasia 6

Decreased appetite 4

Hyperglycaemia 4

Anorexia 2

Weight loss 2

Hypernatremia 2

Hypoglycaemia 2

Drug prescribing error 2

Lethargy (see also Central nervous system depression in Neurological) 2

Localised hair loss 2

Ketonuria 2

Elevated blood urea nitrogen (BUN) 2

Outcome Breakdown

Ongoing

7 (38.9%)

Euthanized

6 (33.3%)

Outcome Unknown

3 (16.7%)

Recovered/Normal

1 (5.6%)

Recovered with Sequela

1 (5.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.